Results 111 to 120 of about 379,515 (350)

Giant renal oncocytoma [PDF]

, 2013
Background. Renal onkocytoma is a distinctive benign tumor derived from epithelial cells of the distal renal tubules. These tumors are often clinically asymptomatic, diagnosed accidentally and difficult to distinguish from renal cell carcinoma.
Ignjatović Ivan, Kostov Miloš, Košević Branko, Mijović Žaklina, Stojanović Nebojša, Živković Sladjana   +5 more
core   +1 more source

Papillary renal cell carcinoma with high‐ABCC2 shows an immune‐evasive profile associated with favorable response to immunotherapy

The Journal of Pathology, EarlyView.
Abstract The use of immune checkpoint inhibitors is a promising therapeutic strategy for metastatic papillary renal cell carcinoma (PRCC); however, predictive biomarkers remain limited. PRCCs with high ABCC2 expression represent an aggressive subset frequently associated with metastasis.
Vincent Francis Castillo, Abraam Zakhary, Fabio Rotondo, Caterina Di Ciano‐Oliveira, Malek Hamdani, Emelyn Adona, Theodorus van der Kwast, Kiril Trpkov, Rola Saleeb   +8 more
wiley   +1 more source

Utilization of aggregation‐induced emission materials in urinary system diseases

Aggregate
With the development of aggregation‐induced emission (AIE) materials, the drawbacks of conventional fluorescence materials subjected to aggregation‐caused quenching (ACQ) have been resolved.
Haodong Xu, Xin Chen, He Wang, Chaozhong Wang, Yunjie Guo, Yuxin Lin, Yuhua Huang, Jianquan Hou, Xuedong Wei   +8 more
doaj   +1 more source

Non-transitional cell carcinoma of the upper urinary tract:A case series among 305 cases at a tertiary urology institute

Urology Annals, 2017
Non-transitional cell carcinomas (non-TCC) of the upper urinary tract as squamous cell carcinoma (SCC), adenocarcinoma, and small cell carcinoma (SmCC) are rare with few case reports in the literature.
Mohamed Mohamed Elawdy, Diaa-Eldin Taha, Yasser Osman, Mohamed Abd El-Hamid, Mohsen El-Mekresh   +4 more
doaj   +1 more source

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer

The Prostate, EarlyView.
ABSTRACT Objective To evaluate the value of circulating free DNA (cfDNA) in prostate cancer (PCa) by cfDNA assay and analysis of plasma and urinary cfDNA fragmentation to determine the usefulness of this parameter for risk staging and tumor progression monitoring.
Marta Victoria Lorenzo‐Sánchez, José Miguel Giménez‐Bachs, María Granada Picazo‐Martínez, María José Donate‐Moreno, Carlos Martínez‐Sánchiz, María Amalia Tárraga‐Honrubia, Sonsoles Navarro‐Jiménez, Óscar Legido‐Gómez, Antonio Santiago Salinas‐Sánchez   +8 more
wiley   +1 more source

Prognostic effect of pretreatment serum gamma-glutamyl transferase in urological malignancies: a systematic review and meta-analysis

Frontiers in Oncology
BackgroundThis study aimed ​​to investigate​​ the association between pretreatment serum gamma-glutamyltransferase (GGT) and survival outcomes in patients with urological malignancies, such as urothelial carcinoma (UCa), renal cell carcinoma (RCC), and ...
Feifan Song, Shiqiang Su, Xueqiao Zhang, Xiongjie Cui, Chao Li, Shen Li   +5 more
doaj   +1 more source

Long‐Term Follow‐Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial

The Prostate, EarlyView.
ABSTRACT Introduction Neoadjuvant intense androgen deprivation therapy (ADT) with androgen receptor signaling inhibitors (ARSIs) has shown pathologic complete responses (pCR) in prostate cancer (PCa), but long‐term survival outcomes remain unclear. This study evaluates the durability of response following neoadjuvant ADT plus enzalutamide before robot ...
Braden Millan, Nikhil Pramod, Ruben Blachman‐Braun, Jaskirat Saini, Lauren Loebach, Milan Patel, Sandeep Gurram, Baris Turkbey, Fatima Karzai, Peter A. Pinto   +9 more
wiley   +1 more source

[Macroscopic painless hematuria in urologic neoplasms].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1989
A group of 100 patients with urinary system tumours and asymptomatic macroscopic haematuria in the past were analysed retrospectively. The analysis showed that the time between the appearance of macroscopic haematuria and the final diagnosis and treatment was from 18 to 560 days.
W, Szewczyk, K, Lukojć, A, Szurkowski, A, Noga, M, Salamon   +4 more
openaire   +1 more source

Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns

The Prostate, EarlyView.
ABSTRACT Purpose Genetic testing is recommended but underutilized in advanced prostate cancer. Given known disparities affecting Black patients, we assessed genetic testing completion rates by race. Methods Henry Ford Health's electronic medical record was queried for new prostate cancer diagnoses (1/1/2017–6/30/2022).
Kyle C. McElyea, James P. Purtell, Avery K. Supernois, Courtney M. Rose, Farhan Ibrahim, Mohammed A. Baseer, Sunita Ghosh, Clara Hwang   +7 more
wiley   +1 more source

Autofluorescence lifetime augmented reality as a means for real-time robotic surgery guidance in human patients. [PDF]

, 2019
Due to loss of tactile feedback the assessment of tumor margins during robotic surgery is based only on visual inspection, which is neither significantly sensitive nor specific.
Bec, J, Bewley, A, Dochow, S, Farwell, DG, Gandour-Edwards, R, Gorpas, D, Ma, D, Marcu, L, Phipps, J, Popp, J, Sorger, J, Yankelevich, D   +11 more
core   +2 more sources